Novartis Oncology Controller Salaries in Boulder | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
13
TOTAL
RATINGS
160

Novartis Oncology Controller Salaries in Boulder

The average Novartis Oncology Controller in Boulder earns an estimated $116,461 annually. Novartis Oncology's Controller compensation is $6,818 less than the US average for a Controller.

In Boulder, The Finance Department at Novartis Oncology earns $4,829 more on average than the Operations Department.

Last updated 2 years ago.

$47k
$71k
$95k
$118k
$180k
$240k
$300k
$116,461
Average Compensation
$116,461
avg. base

Controller Salaries at Novartis Oncology

In Boulder, Controllers earn $20,555 more than Accounting Managers.

Accounting Manager
$96k*
Senior Accountant
$90k*
Business Analyst
$78k*
Financial Analyst
$77k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Boulder, The Finance Department averages $4,829 more than the Operations Department, and $16,534 less than the Sales Department

Sales
$92,112 Avg. total comp.
+$17k
Finance
$75,578 Avg. total comp.
Operations
$70,749 Avg. total comp.
-$5k

Controller Compensation by Gender (All Companies)

The average female Controller at companies similar size to Novartis Oncology reported making $138,290, while the average male Controller at similar sized companies reported making $133,282.

Controller Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Controller at companies similar size to Novartis Oncology reported making $132,409, while the average Caucasian Controller at similar sized companies reported making $129,306.

How Controllers at Novartis Oncology Rate Their Compensation

The majority of Controllers at Novartis Oncology believe they're not compensated fairly. 100% of Controllers at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company